An unusual adverse event of azathioprine: Cutaneous small vessel vasculitis.
作者信息
Hanai Shunichiro, Kobayashi Kei, Nakagomi Daiki
机构信息
Third Department of Internal Medicine, University of Yamanashi, Chuo-shi, Yamanashi, Japan.
出版信息
Arch Rheumatol. 2021 Jan 14;36(3):467-469. doi: 10.46497/ArchRheumatol.2021.8506. eCollection 2021 Sep.
Abstract
摘要
相似文献
1
An unusual adverse event of azathioprine: Cutaneous small vessel vasculitis.
Arch Rheumatol. 2021 Jan 14;36(3):467-469. doi: 10.46497/ArchRheumatol.2021.8506. eCollection 2021 Sep.
2
Primary Cutaneous Small Vessel Vasculitis.
Curr Treat Options Cardiovasc Med. 2004 Apr;6(2):139-149. doi: 10.1007/s11936-004-0042-3.
3
Clinical approach to cutaneous vasculitis.
Am J Clin Dermatol. 2008;9(2):71-92. doi: 10.2165/00128071-200809020-00001.
4
Protocol for a randomized multicenter study for isolated skin vasculitis (ARAMIS) comparing the efficacy of three drugs: azathioprine, colchicine, and dapsone.
Trials. 2020 Apr 28;21(1):362. doi: 10.1186/s13063-020-04285-3.
5
Leucocytoclastic vasculitis in a patient with azathioprine hypersensitivity.
Postgrad Med J. 1996 Jul;72(849):437-8. doi: 10.1136/pgmj.72.849.437.
6
[Diagnosis and management of small vessel vasculitides].
Duodecim. 2010;126(12):1496-507.
7
Cutaneous vasculitis in SLE.
Lupus Sci Med. 2020 Sep;7(1). doi: 10.1136/lupus-2020-000411.
8
Prednisone plus azathioprine treatment in patients with rheumatoid arthritis complicated by vasculitis.
Arch Intern Med. 1991 Nov;151(11):2249-54.
9
Azathioprine. An effective, corticosteroid-sparing therapy for patients with recalcitrant cutaneous lupus erythematosus or with recalcitrant cutaneous leukocytoclastic vasculitis.
Arch Dermatol. 1991 Apr;127(4):515-22. doi: 10.1001/archderm.127.4.515.
10
Management of cutaneous vasculitis.
Presse Med. 2020 Oct;49(3):104033. doi: 10.1016/j.lpm.2020.104033. Epub 2020 Jul 6.
引用本文的文献
1
Azathioprine-Induced Hypersensitivity Vasculitis.
ACG Case Rep J. 2023 Apr 14;10(4):e00990. doi: 10.14309/crj.0000000000000990. eCollection 2023 Apr.
本文引用的文献
1
Azathioprine-induced interstitial nephritis in an anti-neutrophil cytoplasmic antibody (ANCA) myeloperoxidase (MPO) vasculitis patient.
Eur J Rheumatol. 2018 Jul;5(2):135-138. doi: 10.5152/eurjrheum.2017.17062. Epub 2017 Dec 7.
2
NUDT15 codon 139 is the best pharmacogenetic marker for predicting thiopurine-induced severe adverse events in Japanese patients with inflammatory bowel disease: a multicenter study.
J Gastroenterol. 2018 Sep;53(9):1065-1078. doi: 10.1007/s00535-018-1486-7. Epub 2018 Jun 19.
3
Cutaneous vasculitis: diagnosis and management.
Clin Dermatol. 2006 Sep-Oct;24(5):414-29. doi: 10.1016/j.clindermatol.2006.07.007.
4
Pruritus and leucocytoclastic vasculitis due to azathioprine.
Dermatology. 2005;210(4):366. doi: 10.1159/000084771.
5
Leucocytoclastic vasculitis in a patient with azathioprine hypersensitivity.
Postgrad Med J. 1996 Jul;72(849):437-8. doi: 10.1136/pgmj.72.849.437.
6
A method for estimating the probability of adverse drug reactions.
Clin Pharmacol Ther. 1981 Aug;30(2):239-45. doi: 10.1038/clpt.1981.154.
Zotero 插件